Detection and Characterization of Immunoconglutinins in Patients with Systemic Lupus Erythematosus (SLE): Serial Analysis in Relation to Disease Course

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1992 Nov 1

PMID 1424282

Citations 8

Authors

B Nilsson

K N Ekdahl

A Sjoholm

U R Nilsson

G Sturfelt

Affiliations

Soon will be listed here.

Abstract

The levels of IgA, IgG and IgM immunoconglutinins (IK) were assessed in sera from 20 patients with SLE which were followed for 8-month periods. At the time of the exacerbation, IgG IKs were significantly increased to 226 +/- 90 arbitrary units (mean +/- s.e.m.) compared with both the minimum value of 75 +/- 28 in the SLE patients and with 31 +/- 2 in healthy controls (P < 0.05). There was no difference between SLE patients and controls in the levels of IgM and IgA IKs. Most of the SLE patients in this material showed maximal IgG IK levels before exacerbation, but there was no correlation between the clinical disease index and the levels of IgG IK. The specificity of IgG IKs showed a broad diversity for microtitre-fixed C3b, iC3b, C3c and C3dg. The antibodies were of IgG1, IgG3 and in two patients, IgG4 subclass. IgG IKs were correlated to the C3d/C3 ratio which suggested that the IK responses were secondary to C3 activation. In summary, unlike other conditions associated with complement activation where elevated IgM IKs are common, an increase in IgG IK levels was observed. It is possible that this diverging IK response contributes to the pathophysiology of the disease.

Citing Articles

Clinical Relevance of Anti-C3 and Anti-C4 Autoantibodies in Lupus Nephritis.

Vasilev V, Artero M, Petkova M, Mihaylova G, Dragon-Durey M, Radanova M Kidney Int Rep. 2024; 9(5):1429-1440.

PMID: 38707805 PMC: 11068950. DOI: 10.1016/j.ekir.2024.01.052.

The complement system and human autoimmune diseases.

Coss S, Zhou D, Chua G, Aziz R, Hoffman R, Wu Y J Autoimmun. 2022; 137:102979.

PMID: 36535812 PMC: 10276174. DOI: 10.1016/j.jaut.2022.102979.

Autoantibodies Against C3b-Functional Consequences and Disease Relevance.

Vasilev V, Radanova M, Lazarov V, Dragon-Durey M, Fremeaux-Bacchi V, Roumenina L Front Immunol. 2019; 10:64.

PMID: 30761135 PMC: 6361862. DOI: 10.3389/fimmu.2019.00064.

Interpretation of Serological Complement Biomarkers in Disease.

Ekdahl K, Persson B, Mohlin C, Sandholm K, Skattum L, Nilsson B Front Immunol. 2018; 9:2237.

PMID: 30405598 PMC: 6207586. DOI: 10.3389/fimmu.2018.02237.

Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.

Birmingham D, Bitter J, Ndukwe E, Dials S, Gullo T, Conroy S Clin J Am Soc Nephrol. 2015; 11(1):47-53.

PMID: 26700439 PMC: 4702227. DOI: 10.2215/CJN.03990415.

References

Orstavik K . Inhibitors to factor IX contain all IgG subclasses except IgG3. Folia Haematol Int Mag Klin Morphol Blutforsch. 1990; 117(4):545-8. View

Shirakata Y, Shiraishi S, Sayama K, Miki Y . Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus. J Dermatol. 1990; 17(11):661-6. DOI: 10.1111/j.1346-8138.1990.tb03008.x. View

Nossent J, Huysen V, Smeenk R, Swaak A . Low avidity antibodies to double stranded DNA in systemic lupus erythematosus: a longitudinal study of their clinical significance. Ann Rheum Dis. 1989; 48(8):677-82. PMC: 1003846. DOI: 10.1136/ard.48.8.677. View

LACHMANN P . Conglutinin and immunoconglutinins. Adv Immunol. 1967; 6:479-527. DOI: 10.1016/s0065-2776(08)60527-1. View

Bienenstock J, BLOCH K . Immunoconglutinin in various rheumatic diseases and certain diseases suspected of an autoimmune pathogenesis. Arthritis Rheum. 1967; 10(3):187-98. DOI: 10.1002/art.1780100304. View

Durand C, Burge J . A new enzyme-linked immunosorbent assay (ELISA) for measuring immunoconglutinins directed against the third component of human complement. Findings in systemic lupus erythematosus. J Immunol Methods. 1984; 73(1):57-66. DOI: 10.1016/0022-1759(84)90031-0. View

Bourke B, Moss I, Maini R . Measurement of the complement C3 breakdown product C3d by rocket immunoelectrophoresis. J Immunol Methods. 1982; 48(1):97-108. DOI: 10.1016/0022-1759(82)90214-9. View

Erdei A, Fust G, Gergely J . The role of C3 in the immune response. Immunol Today. 1991; 12(9):332-7. DOI: 10.1016/0167-5699(91)90011-H. View

Brouwer E, Tervaert J, Horst G, Huitema M, VAN DER GIESSEN M, Limburg P . Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol. 1991; 83(3):379-86. PMC: 1535341. DOI: 10.1111/j.1365-2249.1991.tb05647.x. View

10.

Bernard P, Prost C, Aucouturier P, Durepaire N, Denis F, Bonnetblanc J . The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J Invest Dermatol. 1991; 97(2):259-63. DOI: 10.1111/1523-1747.ep12480369. View

11.

Ekdahl K, Nilsson U, Nilsson B . Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies on the specificity of factor I. J Immunol. 1990; 144(11):4269-74. View

12.

Nilsson B, Ekdahl K, Svarvare M, Bjelle A, Nilsson U . Purification and characterization of IgG immunoconglutinins from patients with systemic lupus erythematosus: implications for a regulatory function. Clin Exp Immunol. 1990; 82(2):262-7. PMC: 1535126. DOI: 10.1111/j.1365-2249.1990.tb05437.x. View

13.

Bindon C, Hale G, Bruggemann M, Waldmann H . Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q. J Exp Med. 1988; 168(1):127-42. PMC: 2188986. DOI: 10.1084/jem.168.1.127. View

14.

LAURELL C . Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 1966; 15(1):45-52. DOI: 10.1016/0003-2697(66)90246-6. View

15.

Sturfelt G, Sjoholm A . Complement components, complement activation, and acute phase response in systemic lupus erythematosus. Int Arch Allergy Appl Immunol. 1984; 75(1):75-83. DOI: 10.1159/000233593. View

16.

Druguet M, Chayvialle J, Andre C, Pepys M . Radioimmunoassay for immunoconglutinins. J Immunol Methods. 1980; 34(3):181-90. DOI: 10.1016/0022-1759(80)90045-9. View

17.

HAMMER C, WIRTZ G, Renfer L, Gresham H, Tack B . Large scale isolation of functionally active components of the human complement system. J Biol Chem. 1981; 256(8):3995-4006. View